Biomarkers for Alzheimer's disease

Published: November, 2010

The research advances incrementally, but clinical use is still years away.

The brain changes that lead to Alzheimer's disease probably begin years, and possibly even more than a decade, before symptoms such as memory impairment appear. For this reason, Alzheimer's researchers have long hoped to find biomarkers — early biological signs of disease pathology — that could help identify people at risk before symptoms develop.

To continue reading this article, you must log in.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »